+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "T Type Calcium Channel Blocker"

Voltage-Dependent T-Type Calcium Channel Blockers - Pipeline Insight, 2024 - Product Thumbnail Image

Voltage-Dependent T-Type Calcium Channel Blockers - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
T type calcium channel antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

T type calcium channel antagonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

T Type Calcium Channel Blocker (TCCB) drugs are a class of medications used to treat neurological disorders, such as epilepsy, migraine, and neuropathic pain. They work by blocking the flow of calcium ions into cells, which helps to reduce the excitability of neurons and reduce the frequency of seizures. TCCBs are also used to treat hypertension, cardiac arrhythmias, and other cardiovascular conditions. TCCBs are generally well-tolerated and have few side effects. They are often used in combination with other medications to treat neurological disorders, and may be used as an alternative to benzodiazepines for the treatment of anxiety. The TCCB market is an important part of the Central Nervous System Drugs market, as it provides a range of treatments for neurological disorders. It is a competitive market, with a number of companies offering different types of TCCBs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Merck. Show Less Read more